Partial depletion of regulatory T cells does not influence the inflammation caused by high dose hemi-body irradiation.

There is clinical interest in the modulation of regulatory T cells for cancer therapy. The safety of these therapies in combination with conventional anti-cancer therapies, including radiation therapy, can be studied in animal models. The effects of partial depletion of regulatory T (Treg) cells wit...

Full description

Bibliographic Details
Main Authors: Shihong Ma, James A Richardson, Andrew Bitmansour, Timothy D Solberg, Rajesh Pidikiti, Kwang Song, Strahinja Stojadinovic, Ellen S Vitetta, Jeffrey J Meyer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23409194/?tool=EBI